Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus

This publication has 29 references indexed in Scilit:

• Substitution of Wild‐Type Yellow Fever Asibi Sequences for 17D Vaccine Sequencesin ChimeriVax–Dengue 4 Does Not Enhance Infection ofAedes aegyptiMosquitoes
  The Journal of Infectious Diseases, 2008
• A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial
  The Journal of Infectious Diseases, 2007
• A live, attenuated recombinant West Nile virus vaccine
  Proceedings of the National Academy of Sciences, 2006
• Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus
  Journal of General Virology, 2004
• Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone
  Vaccine, 2004
• Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine
  Journal of Virology, 2003
• West Nile Encephalitis: An Emerging Disease in the United States
  Clinical Infectious Diseases, 2001
• Molecular Organization of a Recombinant Subviral Particle from Tick-Borne Encephalitis Virus
  Molecular Cell, 2001
• A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice
  Vaccine, 2000
• Efficient selection for high-expression transfectants with a novel eukaryotic vector
  Gene, 1991